Symbicort® COPD (budesonide/formoterol)

Symbicort® Turbohaler® and Symbicort® pMDI are combinations of an inhaled corticosteroid and a long-acting β2-agonist 

COPD guidelines

GOLD 201912: Initial Pharmacological treatment algorithm by GOLD grade.

Adapted from GOLD 2019

GOLD 201912: Follow-Up Pharmacological treatment algorithm.

Adapted from GOLD 2019

*Consider if eos ≥ 300 or eos ≥ 100 AND ≥ 2 moderate exacerbations / 1 hospitalisation
**Consider de-escalation of ICS or switch if pneumonia, inappropriate original indication or lack of response to ICS

ICS=inhaled corticosteroids; LABA=long-acting b2-agonist; LAMA=long-acting muscarinic receptor antagonist; eos = blood eosinophil count (cells/µL).